Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Cell MedX Corp.
- Security class
- Common Shares
- Shares / value
- 88,959,726
- Estimated value
- $13,343,959
- Report date
- 29 Dec 2023
- Price
- $0.1500
- Ownership
- Son
David Jeffs
Insider Reports History
- Reporting-owner location
- Vancouver, British Columbia, Canada
- Latest reporting-owner signature
- David Jeffs
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for David Jeffs
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Cell MedX Corp.
- Security class
- Common Shares
- Shares / value
- 81,459,726
- Estimated value
- $12,218,959
- Report date
- 29 Dec 2023
- Price
- $0.1500
- Ownership
- Daughter
Form 4 holding
Chief Executive Officer, Director, 10%+ Owner
Cell MedX Corp.
- Security class
- Common Shares
- Shares / value
- 73,959,726
- Estimated value
- $11,093,959
- Report date
- 29 Dec 2023
- Price
- $0.1500
- Ownership
- Direct
Insider Reports Filed by David Jeffs
4
STME
Cell MedX Corp.
- Report period
- 29 Dec 2023
- Transactions
- 3
- Transaction value
- +$622,718
- Accepted by SEC
- 10 Jan 2024, 13:10
- Role
- Chief Executive Officer, Director, 10%+ Owner
- Next action
- Open filing details
3
STME
Cell MedX Corp.
- Report period
- 12 Dec 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 09 Jan 2024, 15:21
- Role
- CEO, Director
- Next action
- Open filing details